Journal of neuroendocrinologyHumansEverolimusNeuroendocrine TumorsMaleFemale
The relationship between dose, concentration and toxicity of everolimus in the treatment of neuroendocrine tumors: A prospective observational study.
Oddry Henriette Folkestad, Jon Sponheim, Tone Lise Åvitsland, Kjerstin Skrede Mordal, Nils Tore Vethe, Espen Thiis-Evensen
Published: 202610.1111/jne.70107
Abstract
Everolimus is used in the treatment of patients with advanced neuroendocrine tumors (NET) and is administered at fixed doses despite known interpatient pharmacokinetic variability. This may affect both efficacy and tolerability. We wanted to investig…
Preview only. Read the full abstract at the source